UBS Group Portfolio holdings
UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$1.12B |
| 2 |
Apple
AAPL
|
+$1.08B |
| 3 |
Microsoft
MSFT
|
+$1.05B |
| 4 |
Nike
NKE
|
+$1.03B |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$821M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
BioMarin Pharmaceuticals
BMRN
|
+$389M |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$383M |
| 3 |
iShares 7-10 Year Treasury Bond ETF
IEF
|
+$348M |
| 4 |
PXD
Pioneer Natural Resource Co.
PXD
|
+$263M |
| 5 |
NRG Energy
NRG
|
+$237M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.8% |
| 2 | Financials | 8.25% |
| 3 | Healthcare | 6.4% |
| 4 | Consumer Discretionary | 5.85% |
| 5 | Communication Services | 4.91% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3276
Inspire Global Hope ETF
BLES
$164M
| $3.22M | ﹤0.01% |
88,125
+4,366
| +5% | +$161K |
|
3277
Xtrackers Russell US Multifactor ETF
DEUS
$305M
| $3.22M | ﹤0.01% |
63,839
+10,572
| +20% | +$533K |
|
3278
Fastly Inc
FSLY
$3.66B
| $3.21M | ﹤0.01% |
436,158
-5,283
| -1% | -$51.7K |
|
3279
Thor Industries
THO
$4.14B
| $3.21M | ﹤0.01% |
34,334
+42
| +0.1% | +$4.2K |
|
3280
State Street SPDR Dow Jones International Real Estate ETF
RWX
$270M
| $3.21M | ﹤0.01% |
133,612
+61,064
| +84% | +$1.53M |
|
3281
Glacier Bancorp
GBCI
$6.35B
| $3.21M | ﹤0.01% |
85,891
-43,567
| -34% | -$1.62M |
|
3282
Hamilton Lane
HLNE
$5.57B
| $3.2M | ﹤0.01% |
25,887
-21,563
| -45% | -$2.52M |
|
3283
Axsome Therapeutics
AXSM
$10.9B
| $3.2M | ﹤0.01% |
39,704
-21,616
| -35% | -$1.6M |
|
3284
CALL
Avantor
AVTR
$9.19B
| $3.19M | ﹤0.01% |
+150,700
| New | +$3.63M |
|
3285
Grand Canyon Education
LOPE
$3.98B
| $3.19M | ﹤0.01% |
22,822
+2,432
| +12% | +$335K |
|
3286
Aspen Aerogels
ASPN
$518M
| $3.19M | ﹤0.01% |
133,683
-166,348
| -55% | -$3.9M |
|
3287
CALL
D.R. Horton
DHI
$42.3B
| $3.19M | ﹤0.01% |
22,600
+5,000
| +28% | +$735K |
|
3288
PUT
Constellation Energy
CEG
$95.6B
| $3.18M | ﹤0.01% |
15,900
-62,000
| -80% | -$12.6M |
|
3289
Hexcel
HXL
$7.82B
| $3.18M | ﹤0.01% |
50,956
+7,038
| +16% | +$472K |
|
|
CWAN
3290
DELISTED
Clearwater Analytics
CWAN
| $3.18M | ﹤0.01% |
171,749
-831,953
| -83% | -$15M |
|
3291
CALL
Western Midstream Partners
WES
$19.3B
| $3.18M | ﹤0.01% |
+80,000
| New | +$2.94M |
|
3292
Viper Energy
VNOM
$14.7B
| $3.18M | ﹤0.01% |
84,641
-225,723
| -73% | -$8.58M |
|
3293
White Mountains Insurance
WTM
$5.13B
| $3.18M | ﹤0.01% |
1,747
-17
| -1% | -$30.1K |
|
3294
Brookfield Renewable
BEPC
$6.26B
| $3.16M | ﹤0.01% |
111,520
+12,362
| +12% | +$346K |
|
3295
Denali Therapeutics
DNLI
$3.97B
| $3.16M | ﹤0.01% |
136,223
-207,656
| -60% | -$3.99M |
|
|
RMM
3296
RiverNorth Managed Duration Municipal Income Fund
RMM
$290M
| $3.16M | ﹤0.01% |
206,978
+18,102
| +10% | +$269K |
|
3297
Verra Mobility
VRRM
$744M
| $3.16M | ﹤0.01% |
115,996
-8,029
| -6% | -$207K |
|
3298
Itron
ITRI
$4.54B
| $3.15M | ﹤0.01% |
31,852
-29,400
| -48% | -$2.96M |
|
3299
Immunovant
IMVT
$8.25B
| $3.15M | ﹤0.01% |
119,355
-83,195
| -41% | -$2.37M |
|
3300
CALL
Cardinal Health
CAH
$55.4B
| $3.15M | ﹤0.01% |
32,000
+2,000
| +7% | +$204K |
|
Similar funds
UBS Group's Q2 2024 Portfolio in Review
As of Q2 2024, UBS Group held 10,501 positions worth $405B, up 0.81% from $402B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
UBS Group's Q2 2024 filing shows 1,231 new, 3,688 increased, 4,131 reduced and 1,043 closed positions. Its largest new stake was SLB Ltd: 10,925,731 shares worth $515M. The largest sale was BioMarin Pharmaceuticals, an estimated $389M.
By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 15% a quarter earlier, followed by Financials and Healthcare.
- UBS Group's largest Q2 2024 buy was SLB Ltd: 10,925,731 shares worth $515M.
- UBS Group added most to NVIDIA in Q2 2024, an estimated $1.12B increase.
- UBS Group's biggest Q2 2024 reduction was BioMarin Pharmaceuticals, cutting an estimated $389M.
- UBS Group fully exited Pioneer Natural Resource Co. in Q2 2024, selling an estimated $263M.
- UBS Group's ten largest holdings make up 18% of its $405B portfolio in Q2 2024.
- UBS Group opened 1,231 new positions and closed 1,043 in Q2 2024.
- UBS Group's portfolio value rose 0.81% quarter-over-quarter to $405B.
Based on UBS Group's 13F filing for Q2 2024, filed 14 Aug 2024.